Mechanisms and catheter ablation of ventricular tachycardia
1Experimental Electrophysiology Laboratory, Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. vreddy@partners.org
Insights
Ventricular tachycardia (VT) in structural heart disease often arises from the left ventricle, posing life-threatening risks requiring defibrillators. Without structural heart disease, VT typically originates from the right ventricle and is less severe, treatable with drugs or ablation.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Ventricular tachycardia (VT) is a critical arrhythmia.
- Understanding VT origin and characteristics is vital for patient management.
Purpose of the Study:
- To differentiate VT in patients with and without structural heart disease.
- To outline therapeutic approaches based on VT origin and patient condition.
Main Methods:
- Clinical data review of VT patients.
- Analysis of VT origin (left vs. right ventricle).
- Assessment of hemodynamic stability and substrate identification.
Main Results:
- In structural heart disease, VT commonly originates from the left ventricle, is life-threatening, and often necessitates a defibrillator.
- Ablation success in structural heart disease depends on identifying the diseased substrate.
- In the absence of structural heart disease, VT typically originates from the right ventricle, is less life-threatening, and amenable to drug therapy or ablation.
Conclusions:
- VT management strategies differ significantly based on the presence or absence of structural heart disease.
- Identifying the substrate is key for successful ablation in structural heart disease.
- Non-structural VT is generally less severe and has broader initial treatment options.
Abstract:
In summary, in patients who have structural heart disease, VT usually originates from the left ventricle, is frequently life threatening, and a defibrillator is usually required. Ablation can be successful regardless of the hemodynamic stability of the tachycardia and usually depends on whether or not one can identify the diseased substrate. In the absence of structural heart disease, VT usually originates from the right ventricle and oftentimes the outflow tract. It's typically not life threatening, and first-line therapy can be either drugs or ablation.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Cardiopulmonary Resuscitation IV: Pharmacological Management


